US$ 22.05
olympia meds tirzepatide GLP-1 Agonists for Weight Loss Tirzepatide for GLP-1 Therapy in
Description
A switch from semaglutide to tirzepatide does not guarantee fewer GI symptoms

Mar 27, 2026 Timing is perfect

The SURMOUNT-5 trial, published in The New England Journal of Medicine in May 2025, is the first large randomized study to compare tirzepatide and semaglutide directly in adults with obesity

It is important to remember that these are averages